Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chitosan Powder in LEEP for Postoperative Complications
NCT05661708Phase 4Completed
- Sponsor
- Erzincan Military Hospital
- Start
- Dec 2022
- Primary completion
- Mar 2024
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of chitosan in Vaginal hemorrhage (2 arms), sponsored by Erzincan Military Hospital. Primary endpoint: Median early postoperative blood loss at 6 hours. Started Dec 2022; status: completed.
02
Drugs
chitosan
03
Conditions
Vaginal hemorrhage
Beyond the preview
Go deeper on NCT05661708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05661708.